Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection

Vaccine

Volumn 15, Issue 16, 1997, Pages 1784-1790

  Tamura, Shin Ichi ^a   Yajima, Ayako ^a   Hatori, Emiko ^a   Tamura, Shu ^a   Asanuma, Hideki ^a   Suzuki, Yujiro ^b   Aizawa, Chikara ^b   Kurata, Takeshi ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KITASATO INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNITY; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL TOXINS; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FEMALE; H-2 ANTIGENS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, COMBINED;

EID: 0030796336     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00113-8     Document Type: Article

References (24)

1. Tamura, S.-I., Asanuma, H., Tomita, T., Komase, K., Kawahara, K., Danbara, H., Hattori, N., Watanabe, K., Suzuki, Y., Nagamine, T., Aizawa, C., Oya, A. and Kurata, T. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 1083-1089.
2. Hashigucci, K., Ogawa, H., Ishidate, T., Yamashita, R., Kamiya, H., Watanabe, K., Hattori, H., Sato, T., Suzuki, Y., Nagamine, T., Aizawa, C., Tamura, S.-I., Kurata, T. and Oya, A. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. Vaccine 1996, 14, 113-119.
3. Murphy, B. R. and Webster, R. G. Orthomyxoviruses. In Virology (Eds Fields, B. N., Knipe, D. M., Hoeley, P. M., Chanock, R. M., Hirsch, M. S., Melnick, J. L., Monath, T. P., Roizman, B. and Straus, S. E.). Lippincott-Raven, Philadelphia/New York, 1996, 1397 pp.
4. Wilson, I. R. and Cox, J. C. Structural basis of immune recognition of influenza virus hemagglutinin. Annual Review of Immunology 1990, 8, 737-771.
5. Mayer, H. M. Jr., Hopps, H. E., Parleman, P. D. and Ennis, F. A. Review of existing vaccines for influenza. American Journal of Clinical Pathology 1978, 70, 146-152.
6. Hoskins, T. W., Davies, J. R., Smith, A. J., Allchin, A., Miller, C. L. and Pollock, T. M. Influenza at Christ's Hospital. Lancet 1974, 1, 105-106.
7. Couch, R. B. and Kasel, J. A. Immunity to influenza in man. Annual Review of Microbiology 1983, 37, 529-549.
8. Schulman, J. L. and Kilbourne, E. D. Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. Journal of Bacteriology 1965, 89, 170-174.
9. Yetter, R. A., Lehrer, S., Ramphal, R. and Small, P. A. Jr. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infection and Immunity 1980, 29, 654-662.
10. Waldman, R. H., Wigley, F. M. and Small, P. A. Jr. Specificity of respiratory secretion antibody against influenza virus. Journal of Immunology 1970, 105, 1477-1483.
11. Liew, F. Y., Russell, S. M., Appleyard, G., Brand, C. M. and Beale, J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell activity. European Journal of Immunology 1984, 14, 350-356.
12. Brandtzaeg, P. Polymeric IgA is complexed with secretory component (SC) on the surface of human epithelial cells. Scandinavian Journal of Immunology 1978, 8, 30-52.
13. Crago, S. S., Kulhaavy, R. S., Prince, J. and Mestecky, J. Secretory component on epithelial cells is a surface receptor for polymeric immunoglobulins. Journal of Experimental Medicine 1978, 147, 1832-1837.
14. Solari, R. and Kraehenbuhl, J.-P. The biosynthesis of secretory component and its role in the transepithelial transport of IgA dimer. Immunology Today 1985, 6, 17-20.
15. Shvartsman Ya, S. and Zykov, M. P. Secretory anti-influenza immunity. Advances in Immunology 1976, 22, 291-330.
16. Tamura, S.-I., Samegai, Y., Kurata, H., Nagamine, T., Aizawa, C. and Kurata, T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 1988, 6, 409-413.
17. Tamura, S.-I., Ito, Y., Asanuma, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C. and Kurata, T. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. Journal of Immunology 1992, 149, 981-988.
18. Tamura, S.-I., Yamanaka, A., Shimohara, M., Tomita, T., Komase, K., Tsuda, Y., Suzuki, Y., Nagamine, T., Kawahara, K., Danbara, H., Aizawa, C., Oya, A. and Kurata, T. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 419-426.
19. Hirabayashi, Y., Tamura, S.-I., Suzuki, Y., Nagamine, T., Aizawa, C., Shimada, K. and Kurata, T. H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin. Immunology 1991, 72, 329-335.
20. Nashar, T. O., Amin, T., Marcello, A. and Hirst, T. R. Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine 1993, 11, 235-240.
21. Davenport, F. M., Hennessy, A. V., Brandon, F. M., Webster, R. G., Barrett, C. D. Jr. and Lease, G. O. Comparison of serologic and febrile responses in humans to vaccination with influenza A viruses or their hemagglutinins. Journal of Laboratory and Clinical Medicine 1964, 63, 5-13.
22. Tamura, S.-I., Funato, H., Nagamine, T., Aizawa, C. and Kurata, T. Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB. Vaccine 1989, 7, 503-505.
23. Tamura, S.-I., Funato, H., Hirabayashi, Y., Kikuta, K., Suzuki, Y., Nagamine, T., Aizawa, C., Nakagawa, M. and Kurata, T. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. Vaccine 1990, 8, 479-485.
24. Tamura, S.-I., Funato, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C. and Kurata, T. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. European Journal of Immunology 1991, 21, 1337-1344.